Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Clinuvel Pharmaceuticals Ltd CLVLF

Healthcare Biotechnology
Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:CLVLF)

CLINUVEL expands DNA Repair Program

GlobeNewswire March 23, 2021

CLINUVEL to Trial Innovative Drug in Stroke

GlobeNewswire October 27, 2020

First patient dosed in SCENESSE® DNA Repair Program

GlobeNewswire September 15, 2020

CLINUVEL progresses innovative DNA Repair Program

GlobeNewswire September 10, 2020

CLINUVEL Opens VALLAURIX R&D Centre In Singapore

GlobeNewswire August 31, 2020

PRÉNUMBRA® - CLINUVEL's Second Afamelanotide Formulation

GlobeNewswire July 13, 2020

SCENESSE® to be Prescribed in China

GlobeNewswire April 23, 2020

Innovative drug launched for rare, isolating, "light intolerance" disorder

GlobeNewswire April 16, 2020

FDA Approves SCENESSE® For Genetic Disorder

GlobeNewswire October 8, 2019
View More News ››

Opinion & Analysis (OTCPK:CLVLF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:CLVLF)

Be the first to post on this bullboard.

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is an international oil and gas exploration company with a focus on operations and opportunities in the Middle ...
View More »